Latest news and press releases about Adagio Medical Holdings, Inc. (ADGM): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia.
Price
| Price | $0.50 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.35 |
| EV / EBITDA | -1.03 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -202.26% |
| Return on Invested Capital | -62.23% |
| Return on Assets | -57.99% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ALUR · ATHA · COCH · CODX · CTXR · IRIX · LPTX
Explore sector: Healthcare · Medical - Devices
More sections of ADGM: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks